# Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

> **NCT04052048** · — · RECRUITING · sponsor: **Immunis.AI** · enrollment: 2000 (estimated)

## Conditions studied

- Prostate Cancer Aggressiveness

## Interventions

- **DIAGNOSTIC_TEST:** Subtraction Normalized Expression of Phagocytes Blood Test

## Key facts

- **NCT ID:** NCT04052048
- **Lead sponsor:** Immunis.AI
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-09
- **Primary completion:** 2026-11-15
- **Final completion:** 2029-09-30
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04052048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04052048, "Active Surveillance SNEP Assay Registry Trial for Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04052048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*